Insights

Loading spinner
Gathering insights about Apmonia Therapeutics

Apmonia Therapeutics Tech Stack

Apmonia Therapeutics uses 8 technology products and services including oEmbed, Shopify, JSON-LD, and more. Explore Apmonia Therapeutics's tech stack below.

  • oEmbed
    Dev Tools
  • Shopify
    E-commerce
  • JSON-LD
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Essential Addons for Elementor
    Web Platform Extensions
  • jQuery.scrollTo
    Web Tools And Plugins

Media & News

Apmonia Therapeutics's Email Address Formats

Apmonia Therapeutics uses at least 1 format(s):
Apmonia Therapeutics Email FormatsExamplePercentage
F.Last@apmonia-therapeutics.comJ.Doe@apmonia-therapeutics.com
88%
L.First@apmonia-therapeutics.comD.John@apmonia-therapeutics.com
12%

Frequently Asked Questions

Where is Apmonia Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Apmonia Therapeutics's main headquarters is located at 2 Esplanade Roland Garros Reims, Grand Est 51100 France. The company has employees across 1 continents, including Europe.

What is Apmonia Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Apmonia Therapeutics's official website is apmonia-therapeutics.com and has social profiles on LinkedInCrunchbase.

What is Apmonia Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Apmonia Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Apmonia Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2026, Apmonia Therapeutics has approximately 19 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: A. J.Chief Regulatory Officer: L. L.Chief Operating Officer: S. G.. Explore Apmonia Therapeutics's employee directory with LeadIQ.

What industry does Apmonia Therapeutics belong to?

Minus sign iconPlus sign icon
Apmonia Therapeutics operates in the Biotechnology Research industry.

What technology does Apmonia Therapeutics use?

Minus sign iconPlus sign icon
Apmonia Therapeutics's tech stack includes oEmbedShopifyJSON-LDjQuery MigrateSwiperYoast SEOEssential Addons for ElementorjQuery.scrollTo.

What is Apmonia Therapeutics's email format?

Minus sign iconPlus sign icon
Apmonia Therapeutics's email format typically follows the pattern of F.Last@apmonia-therapeutics.com. Find more Apmonia Therapeutics email formats with LeadIQ.

How much funding has Apmonia Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2026, Apmonia Therapeutics has raised $7.6M in funding. The last funding round occurred on Jul 15, 2024 for $7.6M.

When was Apmonia Therapeutics founded?

Minus sign iconPlus sign icon
Apmonia Therapeutics was founded in 2019.

Apmonia Therapeutics

Biotechnology ResearchGrand Est, France11-50 Employees

Apmonia Therapeutics is a clinical-stage biotechnology company developing peptide-based therapies aimed at modulating the tumor microenvironment in solid cancers. Its work targets the protective ecosystem surrounding tumors that supports growth, immune escape, and treatment resistance. The lead candidate, TAX2, targets the TSP-1/CD47 signaling axis and is advancing to Phase 1/2a in advanced solid tumors after favorable preclinical data and a European regulatory clearance to initiate clinical development.

The company is based in Reims, Grand Est, France. In August 2025 it established a dedicated R&D subsidiary in Liège, Belgium, as part of expanding its European footprint, and it strengthened governance with independent board members.

Section iconCompany Overview

Headquarters
2 Esplanade Roland Garros Reims, Grand Est 51100 France
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $7.6M

    Apmonia Therapeutics has raised a total of $7.6M of funding over 4 rounds. Their latest funding round was raised on Jul 15, 2024 in the amount of $7.6M.

  • $1M

    Apmonia Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $7.6M

    Apmonia Therapeutics has raised a total of $7.6M of funding over 4 rounds. Their latest funding round was raised on Jul 15, 2024 in the amount of $7.6M.

  • $1M

    Apmonia Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.